🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It’s an exciting day!! We really need new treatment options for resistant CMV.

Yes 🙌

Yep 👌🏻🤣 NCIC

Bittersweet announcement but after an amazing 2 years as an infectious disease expert I am moving on. I am now an expert in no-fly zones and Eastern European affairs. Excited to make the most of this new opportunity.

I love you all!!! And am so proud of each of you!! Dr Olivia Smibert

ICH AMS pharmacist extraordinaire Karen Urbancic presenting the Infectious Diseases at Austin Health experience of CAPA. Key learnings- tracheal aspirate surveillance helpful for early identification of at risk pts, but early re-imaging with review of diagnosis important ?truly CAPA. #ASID22 #thinkfungus

Announced at #ASID22, congrats to Dr Olivia Smibert recipient of the ASIDANZ $25,000 Research Grant. Her PhD project aims to define the role of the microbiome in determining infectious/immunological outcomes in immune compromised specialty patient populations. buff.ly/2A9M6UA

Congrats Abby! Amazing body of work and incredible outcome 🤩

Please join me in the August challenge where we all attempt to survive the month together

So proud to present this study from our group Infectious Diseases at Austin Health describing our experience with COVID-19 vaccine challenge in patients with prior immediate AEFI, along with our colleagues from Monash Health Murdoch Children's Research Institute (MCRI). Jason Trubiano 🆔 #MedEd #drugallergy pubmed.ncbi.nlm.nih.gov/35924675/

Some really wonderful speakers lined up for #tts Virtual Transplant ID meeting this week! 🫀🫁🩺 Come learn: - from Xenotransplant to transplant tourism - from #COVID19 updates to CAR-T infections - from transplant stewardship to drug-resistance Register: us02web.zoom.us/webinar/regist…

⭐️ Dr Olivia Smibert ⭐️ ASIDANZ presenting Top 5 papers in #TID

Microbiome modulation in the treatment of cancer is here to stay. ⁦Dr Olivia Smibert⁩ in Keynote talk #asid2023 about top 5 papers in immunocompromised ID. ⁦NCIC⁩

Great message from Dr Olivia Smibert at #ASID23 about the emerging evidence around the effect of antibiotics on the microbiome, and its interaction with cancer treatment responses. ASIDANZ Infectious Diseases at Austin Health NCIC #IDTwitter #MedTwitter #antimicrobialstewardship #AMS

Keynote monica slavin at #ECCMID2023 @eccmid speaking about infections in ICH. Big priorities include microbiome, deep data precision medicine “below the iceberg”, optimisation of antimicrobials, building workforce, effective implementation of what we know. NCIC NCAS_Australia

I have had THE best time absorbing knowledge at Fred Hutch Cancer Center #IDSymp23 with the best NCIC crew! Michelle Yong monica slavin Beatrice Sim I have over 278 slide photos and 12 pages of written notes. Welp! 🤓🤓

Annual NCIC symposium: “Pathways to better infection care in cancer” on 6th Oct. Hear from infection, implement’n, health services & digital health experts on ways to improve outcomes of infection in cancer/transplant. Follow link below: cancerandinfections.org

Can’t wait for this fantastic forum and delighted to have been invited to present!

So happy Infectious Diseases at Austin Health could be a collaborating site on this important international Multisite study.

Fellows of Camille Kotton. Camille Nelson Kotton Christian Larsen Anna Apostolopoulou, MD Cesar G. Berto, MD Missing my co-duckling. Dr Olivia Smibert